Ann: Appointment of New Director and Acting CEO, page-7

There you go - credit where its due:

​

"The management team is extremely capable and experienced and I look forward to working again in particular with Dr Andrew Heaton, who was responsible for the discovery of the super-benzopyran
technology platform, Dr Justine Stehn, who along with Professor Peter Gunning are responsible for out anti-tropomyosin assets and the Company’s CSO Dr David Brown," Mr Ross said.

GK was the salesman out front - the people behind the scenes were doing the actual work on the drugs

Professor Gunning’s breakthrough offers a new way of treating children like Oscar. It offers more effective treatments with minimal side effects. But the research team’s work is by no means finished.  The Drug Discovery team at UNSW are currently in a crucial process taking Anisina to clinical trials, firstly in adults and then children.

http://www.thekidscancerproject.org.au/Research/Drug-Discovery-Anisina.aspx